Actos has been prescribed for treating patients with Type II diabetes. The U.S. Food and Drug Administration (FDA) has issued a warning on Actos (pioglitazone hydrochloride) that it has been linked to an increased risk of bladder cancer. This would be the case especially in patients who have used Actos for more than one year.
Patients who have been diagnosed with bladder cancer have been urged not to use Actos. Patients who have had a history of bladder cancer are urged not to use Actos. There are the warnings that the FDA has issued. Actos is a member of a class of drugs known as thiazolidinediones. This class of drugs has been associated with liver and cardiovascular injury.
The side effects that have been listed for Actos users include:
- Increased risk of heart failure
- Increased risk of liver problems
- Increased risk of bone fractures
- Increased risk of bladder cancer
If you or someone you know has been injured or died as a result of taking the pharmaceutical product, Actos, please call us for an immediate free consultation. Robert Kreisman of Kreisman Law Offices has been handling pharmaceutical defect cases for more than 40 years.
With our years of experience in trying and settling pharmaceutical defect cases around the country, Kreisman Law Offices provides the best possible services to our clients. Our service is unmatched. Please call us 24 hours a day at 312.346.0045 or toll free 800.583.8002 for a free and immediate consultation, or complete a contact form online. There is no charge for a consultation that will include an evaluation of your case, assessment of your damages such as lost income, lost wages, medical and hospital bills, past and future pain and suffering, loss of normal life and wrongful death.